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 In 2016, the CDC reported an estimated 20.4% (50 million) of
U.S. adults had chronic pain [1]
 The American Academy of Sleep Medicine estimates
around 30% of U.S. adults have symptoms of insomnia [2]
 And 10% of U.S. adults have severe insomnia with daytime
consequences [2]

Problem
Identification
(2A)

 Anxiety is estimated to affect 40 million U.S. adults
according to the Anxiety and Depression Association of
America, making anxiety disorders the most common
mental illness in the U.S. [3]
 In a 2017-2018 survey of CBD users, 62% identified using CBD
to treat a medical condition [6]
 The top three conditions listed were pain, anxiety, and
depression [6]

 The same survey found the odds of CBD use to treat a
medical condition were 1.44 times greater among nonregular users of Cannabis compared to regular users [6]
 36% of respondents reported CBD as specific or sole therapy
for their identified medical condition [6]

 The demand for CBD products in increasing among
American consumers [5]
 Many companies producing and selling CBD products
have been making unsubstantiated drug claims about
their products – including that CBD can treat, or cure,
cancer [5]

Description
of Need (2B)

 Due to a lack of FDA oversight and enforcement of CBD
products, an estimated 70% of CBD products offered
online could be mislabeled (with both under or overlabeling of the CBD and THC content) [5]
 The lack of meaningful regulation of cannabidiol
products leaves consumers at an increased risk of using
products with unspecified concentrations of CBD and
thus unknown therapeutic value [5]

 There is a lack of general knowledge and understanding
among consumers as to the scientifically substantiated
evidence behind CBD therapy [5]

Cost
Considerations

 Patients suffering from an anxiety disorder are 3-5
times more likely to go to the doctor and 6 times
more likely to be hospitalized for psychiatric
disorders [3]
 A 2016 Fiscal Report from the Vermont Agency of
Human Services Department of Mental Health
identified ‘anxiety and other nonpsychotic
disorders’ as the most common ICD-10 mental
health diagnosis code among outpatient services
(52%) and community rehabilitation programs
(29%) [13]
 In 2017, insufficient sleep among working adults in
the U.S. was estimated to generate an annual
economic loss between $280 billion and $411 billion
[11]

 This loss will range from $299 to $433 billion by 2020 [11]
 And $318 to $456 billion by 2030 [11]

 By 2020, it is projected that retail sales of CBD
products will have increased to $1.9 billion [5]

Community Perspective and Support
 “Patients often ask what CBD can be used for, what dose to take, if it
interacts with their other medications, if it could show up on a drug test,
and if I can write them a prescription…patients that are already on the VT
Medical Marijuana Registry can get access and expertise through
dispensaries…but I don’t really have any great resources and wish I was
better informed myself.”
- Mick Graham, MD

 “I had other friends with chronic pain that tried CBD and it really worked for
them, so I figured I would try out what they had found helpful. I’m not sure
it’s working for me yet, but there’s so many options available that I’m
interested in trying something else. Most of my information has come from
my own research, but I still have a lot of questions about how it works and
why there are different formulations. I really like that it doesn’t give you the
‘high’ of THC though, so I’m hopeful I can find what is right for me.”
– Chittenden County resident and CBD user

 Created an educational trifold leaflet for patients to:
1. Identify the current medical understanding of CBD
2. Address its proven therapeutic potential to-date

Intervention
and
Methodology

3. Pinpoint what to look for when purchasing CBD
products
4. Recommend dosing for specific medical conditions
5. Correct common myths about CBD
6. List local and online resources for more information
7. Encourage conversations with health care providers
 Created a “dot phrase” (CBDPTINFO) on EPIC with
similar information and additional resources for patients
 Shared phrase with physicians at UVMC FMH to include
in patient’s “after visit summary”

Results/Responses
 Handout was offered for distribution at
the UVMMC Family Medicine Hinesburg
office, as well as to individual providers at
that location
 “dot phrase” was shared with UVMMC
FMH providers
 Response to handout and “dot phrase”
was positive among providers
 No formal response data was received
 Providers appreciated the compiled
resources in two formats to share with
patients

Evaluating this Intervention
Effectiveness

Limitations

 Due to time constraints, the effectiveness
of this intervention was not assessed

 Limited follow-up to evaluate handout
utilization and response

 Future assessment could involve:

 Effectiveness is dependent on
adequate distribution to patients

 A survey to patients at FMH regarding:

 If handout provided new information

 Effectiveness is dependent on patient
reading handout or after visit summary

 Whether handout resulted in change in
CBD habits

 Effectiveness is dependent on English
language literacy

 If they felt more confident finding
information on CBD and purchasing CBD
products

 Handout and “dot phrase” limited to
introductory information on CBD

 If they were more likely to discuss CBD with
their healthcare provider(s)

 Impossible to know whether patients
would have found provided
information independently

 Ability to understand handout

 A survey to providers at FMH regarding:
 If patients questions/understanding of CBD
changed following handout distribution
 How frequently they were using the EPIC
“dot phrase”

Recommended Future Interventions
Update and expand handouts in 1 year - due to high turnover rate of
evidenced- base published studies on CBD
Distribute handout to other family medicine offices and providers in
Vermont

Distribute handout to other providers not associated with family medicine

Compile data regarding CBD use among Vermont patients

Connect more patients and providers with Paul Jerard at the Vermont
Cannabinoid Clinic and Ada Puches at the Champlain Valley Dispensaries
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